CO5251449A1 - N-(aminocarbonil)-2-{[(4-metoxi-2,3,6-trimetilfenil)sulfonil]amino}-piperidinil- carboxamida-methylbenzenocarboximidamida con un espaciador de 13 a 25 atomos, unido a un pentasacarido - Google Patents

N-(aminocarbonil)-2-{[(4-metoxi-2,3,6-trimetilfenil)sulfonil]amino}-piperidinil- carboxamida-methylbenzenocarboximidamida con un espaciador de 13 a 25 atomos, unido a un pentasacarido

Info

Publication number
CO5251449A1
CO5251449A1 CO00093231A CO00093231A CO5251449A1 CO 5251449 A1 CO5251449 A1 CO 5251449A1 CO 00093231 A CO00093231 A CO 00093231A CO 00093231 A CO00093231 A CO 00093231A CO 5251449 A1 CO5251449 A1 CO 5251449A1
Authority
CO
Colombia
Prior art keywords
spacer
atoms
trimetilfenil
pentasacose
methylbenzenocarboximidamida
Prior art date
Application number
CO00093231A
Other languages
English (en)
Spanish (es)
Inventor
Van Boeckel Constan Adri Anton
Cornelia Maria Tromp
Geertsen Tamara Theodora Maria
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of CO5251449A1 publication Critical patent/CO5251449A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
CO00093231A 1999-12-07 2000-12-06 N-(aminocarbonil)-2-{[(4-metoxi-2,3,6-trimetilfenil)sulfonil]amino}-piperidinil- carboxamida-methylbenzenocarboximidamida con un espaciador de 13 a 25 atomos, unido a un pentasacarido CO5251449A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204172 1999-12-07

Publications (1)

Publication Number Publication Date
CO5251449A1 true CO5251449A1 (es) 2003-02-28

Family

ID=8240976

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00093231A CO5251449A1 (es) 1999-12-07 2000-12-06 N-(aminocarbonil)-2-{[(4-metoxi-2,3,6-trimetilfenil)sulfonil]amino}-piperidinil- carboxamida-methylbenzenocarboximidamida con un espaciador de 13 a 25 atomos, unido a un pentasacarido

Country Status (23)

Country Link
US (1) US6875755B2 (enExample)
EP (1) EP1237897B1 (enExample)
JP (1) JP4820517B2 (enExample)
KR (1) KR100776607B1 (enExample)
CN (1) CN1195767C (enExample)
AR (1) AR026726A1 (enExample)
AU (1) AU781846B2 (enExample)
BR (1) BR0016217A (enExample)
CA (1) CA2393042C (enExample)
CO (1) CO5251449A1 (enExample)
CZ (1) CZ303385B6 (enExample)
HK (1) HK1047593A1 (enExample)
HU (1) HUP0203471A3 (enExample)
IL (2) IL149628A0 (enExample)
NO (1) NO323059B1 (enExample)
NZ (1) NZ519100A (enExample)
PE (1) PE20010935A1 (enExample)
PL (1) PL202840B1 (enExample)
RU (1) RU2266913C2 (enExample)
SK (1) SK287682B6 (enExample)
TW (1) TWI289566B (enExample)
WO (1) WO2001042262A2 (enExample)
ZA (1) ZA200203799B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2557086A3 (en) * 2001-09-07 2014-11-05 Alchemia Limited Synthetic heparin pentasaccharides
WO2004007468A1 (en) 2002-07-15 2004-01-22 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
WO2004032836A2 (en) 2002-10-07 2004-04-22 Merck & Co., Inc. Antidiabetic beta-amino heterocylcic dipeptidyl peptidase inhibitors
JP4413863B2 (ja) 2002-11-07 2010-02-10 メルク エンド カムパニー インコーポレーテッド 糖尿病の治療又は予防のためのジペチジルペプチダーゼ阻害剤としてのフェニルアラニン誘導体
CA2512546A1 (en) 2003-01-17 2004-08-05 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
JP2006516573A (ja) 2003-01-31 2006-07-06 メルク　エンド　カムパニー　インコーポレーテッド 糖尿病の治療および予防のためのジペプチジルペプチダーゼ阻害薬としての３−アミノ−４−フェニルブタン酸誘導体
WO2004103276A2 (en) 2003-05-14 2004-12-02 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004110436A1 (en) 2003-06-06 2004-12-23 Merck & Co., Inc. Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
US7456204B2 (en) 2003-06-17 2008-11-25 Merck & Co., Inc. Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
CN1882551A (zh) 2003-07-31 2006-12-20 麦克公司 用作用于治疗或预防糖尿病的二肽基肽酶－iv酶抑制剂的六氢二氮杂吖庚因酮
EP1574516A1 (en) 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
HRP20110331T1 (hr) * 2005-10-10 2011-06-30 N.V. Organon Antikoagulantno-antitrombotski dvojni inhibitori, koji sadrže biotinski biljeg
CN102892411B (zh) 2009-12-18 2015-01-21 恩多提斯药业公司 含有合成的低聚糖的药物口服剂型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2147216T3 (es) * 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.
IL126893A (en) * 1997-11-19 2003-05-29 Akzo Nobel Nv Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
NZ508623A (en) * 1998-06-17 2002-11-26 Akzo Nobel Nv Antithrombotic peptide compounds with saccharide radicals

Also Published As

Publication number Publication date
KR20020070988A (ko) 2002-09-11
NO20022689D0 (no) 2002-06-06
RU2266913C2 (ru) 2005-12-27
US20030114361A1 (en) 2003-06-19
PL202840B1 (pl) 2009-07-31
JP4820517B2 (ja) 2011-11-24
EP1237897B1 (en) 2015-01-14
NO20022689L (no) 2002-06-06
KR100776607B1 (ko) 2007-11-16
CA2393042C (en) 2011-06-28
CZ303385B6 (cs) 2012-08-29
BR0016217A (pt) 2002-09-10
PL355484A1 (en) 2004-05-04
CZ20021958A3 (cs) 2002-08-14
WO2001042262A3 (en) 2001-12-13
ZA200203799B (en) 2003-10-29
AU2003801A (en) 2001-06-18
CA2393042A1 (en) 2001-06-14
AR026726A1 (es) 2003-02-26
CN1195767C (zh) 2005-04-06
EP1237897A2 (en) 2002-09-11
SK287682B6 (sk) 2011-06-06
SK7942002A3 (en) 2002-09-10
NZ519100A (en) 2004-09-24
PE20010935A1 (es) 2001-09-20
WO2001042262A2 (en) 2001-06-14
AU781846B2 (en) 2005-06-16
HUP0203471A3 (en) 2003-03-28
IL149628A0 (en) 2002-11-10
TWI289566B (en) 2007-11-11
HK1047593A1 (zh) 2003-02-28
US6875755B2 (en) 2005-04-05
NO323059B1 (no) 2006-12-27
CN1407989A (zh) 2003-04-02
JP2003520208A (ja) 2003-07-02
HUP0203471A2 (hu) 2003-02-28
IL149628A (en) 2010-04-29

Similar Documents

Publication Publication Date Title
CO5140075A1 (es) Agentes terapeuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas
KR960007545A (ko) 합성 흥분성 아미노산
GEP20043241B (en) Compounds for Treatment of Ischemia and Pharmaceutical Compositions Containing the Same
TW200730540A (en) Novel peptide compounds
BRPI0114994B8 (pt) composição de vacina
CO5251429A1 (es) Derivados de ter-butil-(7-metil-imidazo(1,2-a)piridin-3- il)-amina procedimiento para su preparacion, medicamentos que los contienen, su uso para la preparacion de un medicamento para la inhibicion de la no-sintasa y composiciones farmaceuticas que l
PL332725A1 (en) Pharmaceutic compounds
BR9907962A (pt) Composição farmacêntica, composto, e, processo para preparar o mesmo
CO5310550A1 (es) Nuevo derivado de androstano antiinflamatorio, su polimorfo, sus formas cristalinas solvatadas, composiciones farmaceutias, proceso para prepararlo, intermediario
BR9507561A (pt) Ligação de E-selectina P-selectina ou L-selectina para sialil-lewis X ou sialil-lewis A
AR018732A1 (es) Iminoazucares alquilados para prevenir, reducir o revertir la resistencia a la multidroga en el tratamiento quimioterapeutico y composicionfarmaceutica que los contiene.
CO5271666A1 (es) Derivados de pirimidina
AR043929A1 (es) Fases cristalinas de un inhibidor del hcv
CO5251427A1 (es) Oxazolidinonas que tienen la fucion de sulfoximina
EP1108427A3 (en) Compositions for and uses thereof for altering gene expression with phenylacetate and derivatives thereof
RU99108459A (ru) Ингибирование протеасом 26s и 20s инданонами
CO5070569A1 (es) Compuesto de aminoazol o una sal farmaceuticamente aceptable del mismo y medicamento que los contienen
AR026726A1 (es) Nuevos compuestos antitromboticos y composiciones farmaceuticas que los contienen
BG102647A (en) Acyclic nucleoside derivatives
RU2002118117A (ru) Антитромботическое соединение
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
CO4990974A1 (es) Un derivado carbohidrato
ES2130257T3 (es) Nuevos compuestos y conjugados.
MXPA03001744A (es) Tratamiento de artritis y composiciones del mismo.
DE69229722D1 (de) GnRH Analoge

Legal Events

Date Code Title Description
FG Application granted
FD Application lapsed